McCrindle BW, Rowley AH, Newburger JW et al (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135:e927–e999. https://doi.org/10.1161/CIR.0000000000000484

Article  PubMed  Google Scholar 

Duignan S, Doyle SL, McMahon CJ (2019) Refractory Kawasaki disease: diagnostic and management challenges. Pediatr Health Med Ther 10:131–139. https://doi.org/10.2147/PHMT.S165935

Article  CAS  Google Scholar 

Brogan PA, Bose A, Burgner D et al (2002) Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Child 86:286–290. https://doi.org/10.1136/adc.86.4.286

Article  CAS  Google Scholar 

Noval Rivas M, Arditi M (2020) Kawasaki disease: pathophysiology and insights from mouse models. Nat Rev Rheumatol 16:391–405. https://doi.org/10.1038/s41584-020-0426-0

Article  PubMed  PubMed Central  Google Scholar 

Burns JC (2024) The etiologies of Kawasaki disease. J Clin Invest. https://doi.org/10.1172/JCI176938

Article  PubMed  PubMed Central  Google Scholar 

Fujita Y, Nakamura Y, Sakata K et al (1989) Kawasaki disease in families. Pediatrics 84:666–669

PubMed  CAS  Google Scholar 

Uehara R, Yashiro M, Nakamura Y, Yanagawa H (2003) Kawasaki disease in parents and children. Acta Paediatr 92:694–697. https://doi.org/10.1080/08035320310002768

Article  PubMed  CAS  Google Scholar 

Holman RC, Christensen KY, Belay ED et al (2010) Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii. Hawaii Med J 69:194–197

PubMed  PubMed Central  Google Scholar 

Miura M, Kobayashi T, Kaneko T et al (2018) Association of severity of coronary artery aneurysms in patients with Kawasaki disease and risk of later coronary events. JAMA Pediatr 172:e180030. https://doi.org/10.1001/jamapediatrics.2018.0030

Article  PubMed  PubMed Central  Google Scholar 

Newburger JW, Takahashi M, Burns JC et al (1986) The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315:341–347. https://doi.org/10.1056/NEJM198608073150601

Article  PubMed  CAS  Google Scholar 

Durongpisitkul K, Soongswang J, Laohaprasitiporn D et al (2003) Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol 24:145–148. https://doi.org/10.1007/s00246-002-0216-2

Article  PubMed  CAS  Google Scholar 

Han RK, Silverman ED, Newman A, McCrindle BW (2000) Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease. Arch Pediatr Adolesc Med 154:694–699. https://doi.org/10.1001/archpedi.154.7.694

Article  PubMed  CAS  Google Scholar 

Ae R, Makino N, Kuwabara M et al (2022) Incidence of Kawasaki disease before and after the COVID-19 pandemic in Japan: results of the 26th nationwide survey, 2019 to 2020. JAMA Pediatr 176:1217–1224. https://doi.org/10.1001/jamapediatrics.2022.3756

Article  PubMed  PubMed Central  Google Scholar 

Kido S, Ae R, Kosami K et al (2019) Seasonality of i.v. immunoglobulin responsiveness in Kawasaki disease. Pediatr Int 61:539–543. https://doi.org/10.1111/ped.13863

Article  PubMed  CAS  Google Scholar 

Kim GB, Park S, Eun LY et al (2017) Epidemiology and clinical features of Kawasaki disease in South Korea, 2012–2014. Pediatr Infect Dis J 36:482–485. https://doi.org/10.1097/INF.0000000000001474

Article  PubMed  Google Scholar 

Tremoulet AH, Best BM, Song S et al (2008) Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr 153:117–121. https://doi.org/10.1016/j.jpeds.2007.12.021

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kim T, Choi W, Woo CW et al (2007) Predictive risk factors for coronary artery abnormalities in Kawasaki disease. Eur J Pediatr 166:421–425. https://doi.org/10.1007/s00431-006-0251-8

Article  PubMed  Google Scholar 

Barman P, Pilania RK, Cv G et al (2024) Treatment intensification in Kawasaki disease - current perspectives. Expert Rev Clin Immunol 20:1179–1191. https://doi.org/10.1080/1744666X.2024.2378900

Article  PubMed  CAS  Google Scholar 

Kuniyoshi Y, Tsujimoto Y, Banno M et al (2023) Prediction models for intravenous immunoglobulin resistance in Kawasaki disease: a meta-analysis. Pediatrics. https://doi.org/10.1542/peds.2022-059175

Article  PubMed  Google Scholar 

Liu J, Yuan P, Pang Y, Su D (2023) Polymorphism (rs7251246 T > C), coronary artery aneurysms, and thrombosis in patients with Kawasaki disease in a Southern Han Chinese population. Front Immunol 14:1184162. https://doi.org/10.3389/fimmu.2023.1184162

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ferdosian F, Dastgheib SA, Hosseini-Jangjou SH et al (2021) Association of TNF- α rs1800629, CASP3 rs72689236 and FCGR2A rs1801274 polymorphisms with susceptibility to Kawasaki disease: a comprehensive meta-analysis. Fetal Pediatr Pathol 40:320–336. https://doi.org/10.1080/15513815.2019.1707917

Article  PubMed  CAS  Google Scholar 

Lin MT, Wang JK, Yeh JI et al (2011) Clinical implication of the C allele of the ITPKC gene SNP rs28493229 in Kawasaki disease: association with disease susceptibility and BCG scar reactivation. Pediatr Infect Dis J 30:148–152. https://doi.org/10.1097/INF.0b013e3181f43a4e

Article  PubMed  Google Scholar 

Khor CC, Davila S, Breunis WB et al (2011) Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet 43:1241–1246. https://doi.org/10.1038/ng.981

Article  PubMed  CAS  Google Scholar 

Onouchi Y, Gunji T, Burns JC et al (2008) ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 40:35–42. https://doi.org/10.1038/ng.2007.59

Article  PubMed  CAS  Google Scholar 

Onouchi Y, Ozaki K, Buns JC et al (2010) Common variants in CASP3 confer susceptibility to Kawasaki disease. Hum Mol Genet 19:2898–2906. https://doi.org/10.1093/hmg/ddq176

Article  PubMed  PubMed Central  CAS  Google Scholar 

Onouchi Y, Ozaki K, Burns JC et al (2012) A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet 44:517–521. https://doi.org/10.1038/ng.2220

Article  PubMed  CAS  Google Scholar 

Onouchi Y (2018) The genetics of Kawasaki disease. Int J Rheum Dis 21:26–30. https://doi.org/10.1111/1756-185X.13218

Article  PubMed  Google Scholar 

Xie X, Shi X, Liu M (2018) The roles of genetic factors in Kawasaki disease: a systematic review and meta-analysis of genetic association studies. Pediatr Cardiol 39:207–225. https://doi.org/10.1007/s00246-017-1760-0

Article  PubMed  Google Scholar 

Weng KP, Hsieh KS, Hwang YT et al (2010) IL-10 polymorphisms are associated with coronary artery lesions in acute stage of Kawasaki disease. Circ J 74:983–989. https://doi.org/10.1253/circj.cj-09-0801

Article  PubMed  CAS  Google Scholar 

Meng L, Zhen Z, Jiang Q et al (2021) Predictive model based on gene and laboratory data for intravenous immunoglobulin resistance in Kawasaki disease in a Chinese population. Pediatr Rheumatol Online J 19:95. https://doi.org/10.1186/s12969-021-00582-6

Article